Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells

Molecular Pharmacology

Volumn 54, Issue 6, 1998, Pages 1046-1054

  Kitamura, Yoshihisa ^a   Kosaka, Tadashi ^a   Kakimura, Jun Ichi ^a   Matsuoka, Yasuji ^a   Kohno, Yasuko ^b   Nomura, Yasuyuki ^c   Taniguchi, Takashi ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b NIPPON BOEHRINGER INGELHEIM CO LTD   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; ANTIPARKINSON AGENT; BROMOCRIPTINE; CASPASE 3; DNA FRAGMENT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PRAMIPEXOLE; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; TALIPEXOLE;

APOPTOSIS; ARTICLE; CHROMATIN CONDENSATION; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY;

EID: 0032408087     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.54.6.1046     Document Type: Article

References (14)

1. 2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats. Pharmacol Toxicol 62:121-130.
2. Carlson MD, Kish PE, and Ueda T (1989) Glutamate uptake into synaptic vesicles: competitive inhibition by bromocriptine. J Neurochem 53:1889-1894.
3. Castellani R, Smith MA, Richey PL, and Perry G (1996) Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Res 737:195-200
4. Davis GC, Williams AC, Markey SP, Ebert MH, Caine ED, Reichert CM, and Kopin IJ (1979) Chronic parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatr Res 1:249-254.
5. L is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res 55:2576-2582.
6. Farooqui SM (1994) Induction of adenylate cyclase sensitive dopamine D2-receptors in retinoic acid induced differentiated human neuroblastoma SH-SY5Y cells. Life Sci 55:1887-1893.
7. Greenlund LJS, Deckwerth TL, and Johnson EM Jr (1995) Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron 14:303-315.
8. Hockenbery DM, Oltivai ZN, Yin X-M, Milliman CL, and Korsmeyer SJ (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-251.
9. +) causes DNA fragmentation and increases the Bcl-2 expression in human neuroblastoma, SHSY5Y cells, through different mechanisms. Brain Res 704:240-245.
10. Reed JC, Meister L, Tanaka S, Cuddy M, Yum S, Geyer C, and Pleasure D (1991) Differential expression of bcl-2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin. Cancer Res 51:6529-6538.
11. Ross RA and Biedler JL (1985) Presence and regulation of tyrosinase activity in of human neuroblastoma cell variants in vitro. Cancer Res 45:1628-1632.
12. Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB, and Marsden CD (1989) Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1:1269.
13. Shimizu S, Eguchi Y, Kamiike W, Waguri S, Uchiyama Y, Matsuda H, and Tsujimoto Y (1996) Bcl-2 blocks loss of mitchondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors. Oncogene 13:21-29.
14. Snyder SH and D'Amato RJ (1986) MPTP: A neurotoxin relevant to the pathophysiology of Parkinson's disease. Neurology 36:250-258.